Abstract
BackgroundDepression necessitating assistance from health professionals has a lifetime prevalence of 10%. Chronic disease increases comorbidity with mood and/or anxiety disorders. Patients with chronic pulmonary disease present with severely impaired functionality, chronic somatic and psychogenic pain, require frequent hospitalizations and have a dependency upon medical and nursing personnel. In the present study we assessed anxiety and depression in patients hospitalized for pulmonary disease in a pulmonary disease hospital.MethodsWe assessed anxiety, using the Spielberger state-trait anxiety scale, and depression, using the Beck Depression Inventory, in 132 patients with pulmonary disease.ResultsA total of 49.2% of the sample had moderate or severe depression and 26.5% had anxiety. Women had higher depression and anxiety scores than men (t test, p < 0.05). Depression was positively correlated with anxiety, age and time from diagnosis. Anxiety was positively correlated with depression and time from diagnosis (Pearson r = 0.62 and 0.29, p < 0.01). Patients with chronic obstructive pulmonary disease and bronchial asthma had higher depression scores than patients with tuberculosis (t test, p < 0.01).ConclusionDepression and anxiety are very prevalent in patients with pulmonary disease, especially chronic disease. This may be a very important negative factor in patients' adaptation to the chronic course of their disease.
Highlights
Depression necessitating assistance from health professionals has a lifetime prevalence of 10%
Women had higher anxiety and depression scores than men; 49.2% of the sample had moderate to severe depression, and 44.0% of men had depression symptoms compared to 55.6% of women, whilst 21.8% of men had anxiety symptoms compared to 33.3% of women (Table 1)
Anxiety was higher in patients with chronic obstructive pulmonary disease (COPD) compared to patients with TB
Summary
Depression necessitating assistance from health professionals has a lifetime prevalence of 10%. Depression, necessitating assistance from health professionals, has a lifetime prevalence of 10% [1]. Chronic disease increases comorbidity with mood and/or anxiety disorders. The more serious the somatic disease is, the more probable it will be accompanied by mood and/or anxiety symptoms of variable severity. Failure to manage such mental health problems increases the patients' probability of suffering from complications, even lethal. The lifetime prevalence of mood disorder in patients with chronic disease is 8.9% to 12.9%, with a 6-month prevalence of 5.8% to 9.4%. The lifetime prevalence of mood disorder in patients with chronic disease is 8.9% to 12.9%, with a 6-month prevalence of 5.8% to 9.4%. [3,4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
